daonil 5mg tablets is a medication that contains glibenclamide, a sulfonylurea class drug. Its primary mechanism involves stimulating the pancreatic beta cells to secrete insulin in response to elevated blood glucose levels. By enhancing insulin secretion, glibenclamide helps lower blood sugar levels, particularly after meals. This action is complemented by a reduction in hepatic glucose production, improving overall glucose utilization in the body. Additionally, glibenclamide may enhance insulin sensitivity in peripheral tissues, further contributing to glycemic control.
Indications and Uses of daonil 5mg tablets
- Management of type 2 diabetes mellitus in conjunction with lifestyle modifications.
- Used when dietary changes and exercise are insufficient to achieve adequate glycemic control.
Side Effects of daonil 5mg tablets
- Hypoglycemia (low blood sugar)
- Gastrointestinal disturbances such as nausea and diarrhea
- Weight gain
- Skin reactions like rash or itching
- Allergic reactions
Storage and Handling
Store daonil 5mg tablets in a cool, dry place away from direct sunlight. Keep out of reach of children. Avoid freezing the medication.
Patient Advice and Precautions
It is crucial to monitor blood glucose levels regularly while taking daonil. Patients should be aware of the signs of hypoglycemia and know how to manage it. Inform healthcare providers of any other medications being taken to avoid potential interactions. Always consider lifestyle changes, including diet and exercise, as critical components of diabetes management.
Scientific Degree: pharmacist
Country: Egypt
Clinical Pharmacist | Medical & Pharmaceutical Content Writer & Reviewer
A licensed Egyptian pharmacist registered with the Egyptian Pharmacists Syndicate, holding a Bachelor of Pharmaceutical Sciences (B.Pharm.) from the Faculty of Pharmacy, Cairo University in Pharmaceutical Chemistry. She possesses extensive hands-on experience in community pharmacy practice and clinical patient education, specializing in pharmacokinetics, drug-drug interactions, and evidence-based dosing guidelines for both adults and pediatrics.
Dr. Nada serves as a medical writer and reviewer at Rosheta, dedicated to simplifying complex pharmacological data for patients while delivering accurate, up-to-date clinical insights rooted in approved prescribing information and official regulatory standards, including the Egyptian Drug Authority (EDA) and the U.S. FDA.
Published Date: 15 August 2025
Source 1 :
DRUG GLIBENCLAMIDE
you should ask your doctor before taking this medicine